Literature DB >> 20127017

Adhesion of ST6Gal I-mediated human colon cancer cells to fibronectin contributes to cell survival by integrin beta1-mediated paxillin and AKT activation.

Minyoung Lee1, Jung-Jin Park, Yun-Sil Lee.   

Abstract

We have recently demonstrated that ionizing radiation (IR) of cells increased the expression of beta-galactoside alpha-(2,6)-sialyltransferase (ST6Gal I) and the level of glycoprotein sialylation, especially for the key adhesion molecule integrin beta1. In addition, ST6Gal I-mediated sialylation of integrin beta1 contributed to cell adhesion-mediated radioresistance in colon cancer cells. In this study, we examined IR-induced cell adhesion to the extracellular matrix and evaluated the role of integrin beta1-associated downstream signaling molecules, such as paxillin and AKT. IR exposure and ST6Gal I overexpression increased adhesion of SW480 colon cancer cells to fibronectin and contributed to cell survival through the activation of paxillin and AKT. In contrast, knockdown of ST6Gal I or paxillin reduced the level of radiation-induced cell adhesion and increased the level of cell death. These results suggest that integrin beta1 sialylation may play a critical role in promoting adhesion of cancer cells by integrin beta1-mediated paxillin and AKT activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127017

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  19 in total

1.  Molecular phylogeny and functional genomics of beta-galactoside alpha2,6-sialyltransferases that explain ubiquitous expression of st6gal1 gene in amniotes.

Authors:  Daniel Petit; Anne-Marie Mir; Jean-Michel Petit; Christine Thisse; Philippe Delannoy; Rafael Oriol; Bernard Thisse; Anne Harduin-Lepers
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

2.  Phosphatase and Tensin Homolog (PTEN) Represses Colon Cancer Progression through Inhibiting Paxillin Transcription via PI3K/AKT/NF-κB Pathway.

Authors:  Ling-Li Zhang; Gang-Gang Mu; Qian-Shan Ding; Yan-Xia Li; Yun-bo Shi; Jin-Fen Dai; Hong-Gang Yu
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

3.  The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential.

Authors:  Colleen M Britain; Kaitlyn A Dorsett; Susan L Bellis
Journal:  J Biol Chem       Date:  2017-01-30       Impact factor: 5.157

Review 4.  Claudin proteins, outside-in signaling, and carcinogenesis.

Authors:  Amar B Singh; Srijayaprakash B Uppada; Punita Dhawan
Journal:  Pflugers Arch       Date:  2016-12-17       Impact factor: 3.657

5.  ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.

Authors:  Andrew T Holdbrooks; Colleen M Britain; Susan L Bellis
Journal:  J Biol Chem       Date:  2017-12-12       Impact factor: 5.157

6.  Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells.

Authors:  Amanda F Swindall; Susan L Bellis
Journal:  J Biol Chem       Date:  2011-05-05       Impact factor: 5.157

Review 7.  Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.

Authors:  Gagan Deep; Rajesh Agarwal
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

8.  α2,6-linked sialic acids on N-glycans modulate the adhesion of hepatocarcinoma cells to lymph nodes.

Authors:  Shujing Wang; Xixi Chen; Anwen Wei; Xiao Yu; Bachir Niang; Jianing Zhang
Journal:  Tumour Biol       Date:  2014-10-11

9.  The sialyltransferase ST6GAL1 protects against radiation-induced gastrointestinal damage.

Authors:  Patrick R Punch; Eric E Irons; Charles T Manhardt; Himangi Marathe; Joseph T Y Lau
Journal:  Glycobiology       Date:  2020-07-20       Impact factor: 4.313

10.  The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.

Authors:  Matthew J Schultz; Andrew T Holdbrooks; Asmi Chakraborty; William E Grizzle; Charles N Landen; Donald J Buchsbaum; Michael G Conner; Rebecca C Arend; Karina J Yoon; Christopher A Klug; Daniel C Bullard; Robert A Kesterson; Patsy G Oliver; Amber K O'Connor; Bradley K Yoder; Susan L Bellis
Journal:  Cancer Res       Date:  2016-05-23       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.